Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

R Leurs

Showing results (121-130 of 141) with videos related to

Pageof 15
Sort By:
The Journal of Pharmacology and Experimental Therapeutics|February 12, 1998
Novel qualitative structure-activity relationships for the antinociceptive actions of H2 antagonists, H3 antagonists and derivativesL B Hough, J W Nalwalk, B Y Li, et al.
Bioorganic & Medicinal Chemistry Letters|September 4, 2007
Antinociceptive activity of furan-containing congeners of improgan and ranitidineL B Hough, W M P B Menge, A C van de Stolpe, et al.
The European Journal of Neuroscience|November 21, 1998
Molecular cloning and characterization of an invertebrate homologue of a neuropeptide Y receptorC P Tensen, K J Cox, J F Burke, et al.
Proceedings of the National Academy of Sciences of the United States of America|June 25, 1996
Inverse agonism of histamine H2 antagonist accounts for upregulation of spontaneously active histamine H2 receptorsM J Smit, R Leurs, A E Alewijnse, et al.
Thrombosis and Haemostasis|March 1, 2005
Different effects of low-dose transdermal and oral oestrogen therapy on procarboxy-peptidase U, an inhibitor of fibrinolysis, in healthy postmenopausal women: a randomised, placebo-controlled studyMarinka S Post, Judith R Leurs, Marius J van der Mooren, et al.
The Journal of Pharmacology and Experimental Therapeutics|April 4, 2007
In vitro pharmacology of clinically used central nervous system-active drugs as inverse H(1) receptor agonistsR A Bakker, M W Nicholas, T T Smith, et al.
Brain Research|October 18, 2000
Improgan, a cimetidine analog, induces morphine-like antinociception in opioid receptor-knockout miceL B Hough, J W Nalwalk, Y Chen, et al.
Molecular Pharmacology|February 24, 2004
8R-lisuride is a potent stereospecific histamine H1-receptor partial agonistR A Bakker, D M Weiner, T ter Laak, et al.
Menopause (New York, N.Y.)|January 13, 2004
Raloxifene reduces procarboxypeptidase U, an antifibrinolytic marker. A 2-year randomized, placebo-controlled study in healthy early postmenopausal womenTatjana E Vogelvang, Judith R Leurs, Marius J van der Mooren, et al.
British Journal of Pharmacology|September 3, 2011
Pharmacological characterization of a small-molecule agonist for the chemokine receptor CXCR3D J Scholten, M Canals, M Wijtmans, et al.
Pageof 15

Showing results (121-130 of 141) with videos related to

Sort By:
Pageof 15
The Journal of Pharmacology and Experimental Therapeutics|February 12, 1998
Novel qualitative structure-activity relationships for the antinociceptive actions of H2 antagonists, H3 antagonists and derivativesL B Hough, J W Nalwalk, B Y Li, et al.
Bioorganic & Medicinal Chemistry Letters|September 4, 2007
Antinociceptive activity of furan-containing congeners of improgan and ranitidineL B Hough, W M P B Menge, A C van de Stolpe, et al.
The European Journal of Neuroscience|November 21, 1998
Molecular cloning and characterization of an invertebrate homologue of a neuropeptide Y receptorC P Tensen, K J Cox, J F Burke, et al.
Proceedings of the National Academy of Sciences of the United States of America|June 25, 1996
Inverse agonism of histamine H2 antagonist accounts for upregulation of spontaneously active histamine H2 receptorsM J Smit, R Leurs, A E Alewijnse, et al.
Thrombosis and Haemostasis|March 1, 2005
Different effects of low-dose transdermal and oral oestrogen therapy on procarboxy-peptidase U, an inhibitor of fibrinolysis, in healthy postmenopausal women: a randomised, placebo-controlled studyMarinka S Post, Judith R Leurs, Marius J van der Mooren, et al.
The Journal of Pharmacology and Experimental Therapeutics|April 4, 2007
In vitro pharmacology of clinically used central nervous system-active drugs as inverse H(1) receptor agonistsR A Bakker, M W Nicholas, T T Smith, et al.
Brain Research|October 18, 2000
Improgan, a cimetidine analog, induces morphine-like antinociception in opioid receptor-knockout miceL B Hough, J W Nalwalk, Y Chen, et al.
Molecular Pharmacology|February 24, 2004
8R-lisuride is a potent stereospecific histamine H1-receptor partial agonistR A Bakker, D M Weiner, T ter Laak, et al.
Menopause (New York, N.Y.)|January 13, 2004
Raloxifene reduces procarboxypeptidase U, an antifibrinolytic marker. A 2-year randomized, placebo-controlled study in healthy early postmenopausal womenTatjana E Vogelvang, Judith R Leurs, Marius J van der Mooren, et al.
British Journal of Pharmacology|September 3, 2011
Pharmacological characterization of a small-molecule agonist for the chemokine receptor CXCR3D J Scholten, M Canals, M Wijtmans, et al.
Pageof 15